[1] Michelson A D. Flow cytometry: a clinical test of platelet function[J]. Blood, 1996,87(12):4925-4936.[2] Harrison P,Segal H,Briggs C,et al. Impact of immunological platelet counting(by the platelet/RBC ratio)on haematological practice[J].Cytometry B Clin Cytom,2005,67(1):1-5.[3] Macey M, McCarthy D, Azam U, et al. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole(EDTA—CTAD):a novel anticoagulant for the flow cytometfic assessment of platelet and neutrophil activation ex vivo in whole blood[J].Cytometry B Clin Cytom,2003,51(1):30-40.[4] 中华医学会检验医学分会,卫生部临床检验中心,中华检验医学杂志编辑委员会.流式细胞术临床应用的建议[J].中华检验医学杂志,2013,36(12):1064-1073.[5] van Velzen J F, Laros-van Gorkom B A, Pop G A, et al. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers[J]. Thromb res, 2012,130(1):92-98.[6] Bagamery K,Kvell K,Landau R,et al. Flow cytometric analysis of CD41-labeled platelets isolated by the rapid,one-step OptiPrep method from human blood[J].Cytometry A,2005,65(1):84-87.[7] Ferroni P, Vazzana N, Riondino S, et al. Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities[J]. Antioxid Redox Signal, 2012,17(10):1447-1485.[8] Price M J. The evidence base for platelet function testing in patients undergoing percutaneous coronary intervention[J]. Circ Cardiovasc Interv, 2010,3(3):277-283.[9] Yu L H,Kim M H,Zhang H Z,et al. Impact of platelet function test on platelet responsiveness and clinical outcome after coronary stent implantation: platelet responsiveness and clinical outcome[J]. Korean Circ J,2012,42(6):382-389.[10] Pendyala L K,Torguson R,Loh J P,et al. Racial disparity with on-treatment platelet reactivity in patients undergoing percutaneous coronary interventionl[J].Am Hcart J,2013,166(2):266-272.[11] 王建中,曹凌,贺茂林,等. 流式细胞术三色分析循环活化血小板及其在缺血性脑血管病中的临床意义[J]. 中华医学杂志,2000,80(7):499-502.[12] 庞博,刘贵建.血液细胞分析技术的临床应用与研究进展[J]. 首都医科大学学报,2013,34(4):550-553.[13] 笪正,翟正平,闫福岭.急性脑梗死进展发生的相关危险因素分析[J]. 中国脑血管病杂志,2014,11(11):569-575.[14] Cao Y J, Wang Y M, Zhang J, et al. The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction[J]. J Thromb Thrombolysis,2009, 27(2):233-238.[15] Yildirim N, Tekin I O, Arasli M,et al. Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone[J]. Mediators Inflamm,2010, 2010: 748919. |